(Q27302402)

English

Induction of selective blood-tumor barrier permeability and macromolecular transport by a biostable kinin B1 receptor agonist in a glioma rat model

scientific article

In more languages

Statements

scholarly article

0 references

Induction of selective blood-tumor barrier permeability and macromolecular transport by a biostable kinin B1 receptor agonist in a glioma rat model (English)

0 references

1 reference

based on heuristic

inferred from title

object named as

Martin Lepage

10

0 references

Werner Müller-Esterl

8

object named as

Werner Müller-Esterl

0 references

11

object named as

David Fortin

0 references

Witold Neugebauer

6

object named as

Witold Neugebauer

0 references

4

object named as

Céléna Dubuc

0 references

Veronica Bovenzi

2

object named as

Veronica Bovenzi

0 references

5

object named as

Audrey Fortier

0 references

author name string

Jérôme Côté

1

0 references

Martin Savard

3

0 references

Luc Tremblay

7

0 references

Ana-Maria Tsanaclis

9

0 references

Fernand Gobeil

12

0 references

language of work or name

0 references

publication date

2012

0 references

0 references

7

0 references

5

0 references

e37485

0 references

copyright license

Creative Commons Attribution 4.0 International

21 May 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Enhancement of blood-tumor barrier permeability by Sar-[D-Phe8]des-Arg9BK, a metabolically resistant bradykinin B1 agonist, in a rat C6 glioma model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

21 March 2017

Astrocyte-endothelial interactions at the blood-brain barrier

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

21 March 2017

International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

21 March 2017

Cereport (RMP-7) increases carboplatin levels in brain tumors after pretreatment with dexamethasone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

21 March 2017

Bradykinin-induced cell migration and COX-2 production mediated by the bradykinin B1 receptor in glioma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

21 March 2017

Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

21 March 2017

Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

7 April 2017

Noncanonical intracrine action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Bradykinin promotes the chemotactic invasion of primary brain tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Convection enhanced delivery of carboplatin in combination with radiotherapy for the treatment of brain tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Cerebral ischemia-reperfusion injury in rats--a 3 T MRI study on biphasic blood-brain barrier opening and the dynamics of edema formation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Combined radio- and chemotherapy of brain tumours in adult patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Novel kinin B1 receptor agonists with improved pharmacological profiles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Structure-activity relationships of novel peptide agonists of the human bradykinin B2 receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Expression of tissue and plasma kallikreins and kinin B1 and B2 receptors in lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Chemotherapy and delivery in the treatment of primary brain tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Recent advances in blood-brain barrier disruption as a CNS delivery strategy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Retinal plasma extravasation in streptozotocin-diabetic rats mediated by kinin B(1) and B(2) receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Strategies to advance translational research into brain barriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Novel expression of kallikreins, kallikrein-related peptidases and kinin receptors in human pleural mesothelioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Standardization and detailed characterization of the syngeneic Fischer/F98 glioma model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Chemotherapy delivery issues in central nervous system malignancy: a reality check.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Molecularly targeted therapy for malignant glioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Novel therapies for hereditary angioedema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

The role of chemotherapy in the treatment of malignant astrocytomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Novel therapies for malignant gliomas: a local affair?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Temporal trends in incidence of primary brain tumors in the United States, 1985-1999

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Metastatic disease of the brain: extra-axial metastases (skull, dura, leptomeningeal) and tumour spread.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Development of novel targeted therapies in the treatment of malignant glioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Metalloendopeptidases EC 3.4.24.15/16 regulate bradykinin activity in the cerebral microvasculature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: from concept to clinical evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Kinin B(1) receptors and the cardiovascular system: regulation of expression and function.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Inflammatory mediators and modulation of blood-brain barrier permeability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Expression of interleukin-1beta mRNA and protein in human gliomas assessed by RT-PCR and immunohistochemistry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Vasomotor and permeability effects of bradykinin in the cerebral microcirculation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Bradykinin and nitric oxide in infectious disease and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Increasing brain cancer rates in Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 September 2017

The role of bradykinin B1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen-induced arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

31 May 2018

Inflammatory leukocytes associated with increased immunosuppression by glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

31 May 2018

Why is the global CNS pharmaceutical market so under-penetrated?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037485

21 January 2018

The role of kinin B1 in the plasma extravasation of carrageenin-induced pleurisy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037485

21 January 2018

Inhibitory effect of a novel bradykinin B1 receptor antagonist, R-954, on enhanced vascular permeability in type 1 diabetic mice

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037485

21 January 2018

Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037485

21 January 2018

Acute effects of bradykinin on cerebral microvascular permeability in the anaesthetized rat.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037485

21 January 2018

Kinin receptors are expressed in human astrocytic tumour cells.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037485

21 January 2018

Extensive intra-tumor heterogeneity in primary human glial tumors as a result of locus non-specific genomic alterations.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037485

21 January 2018

Kinin B1 receptor antagonists containing alpha-methyl-L-phenylalanine: in vitro and in vivo antagonistic activities

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037485

21 January 2018

Modulation of tumor-selective vascular blood flow and extravasation by the stable prostaglandin 12 analogue beraprost sodium

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037485

21 January 2018

Intravenous cereport (RMP-7) enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tumors in the brain.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037485

21 January 2018

Capillary permeability factor secreted by malignant brain tumor. Role in peritumoral brain edema and possible mechanism for anti-edema effect of glucocorticoids

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037485

21 January 2018

Correlation between bradykinin-induced blood-tumor barrier permeability and B2 receptor expression in experimental brain tumors.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037485

21 January 2018

Overexpression of bradykinin type 2 receptors on glioma cells enhances bradykinin-mediated blood-brain tumor barrier permeability increase.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037485

21 January 2018

Enhanced delivery of carboplatin into brain tumours with intravenous Cereport (RMP-7): dramatic differences and insight gained from dosing parameters

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037485

21 January 2018

Bradykinin protects against brain microvascular endothelial cell death induced by pathophysiological stimuli.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037485

21 January 2018

Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037485

21 January 2018

Kinin B1 receptor expression and function on human brain endothelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 November 2018

Enhanced cytokines delivery and intercellular adhesion molecule 1 (ICAM-1) expression in glioma by intracarotid infusion of bradykinin analog, RMP-7.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 November 2018

Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357387

28 November 2018

The B1 receptors for kinins

1 reference

https://pubmed.ncbi.nlm.nih.gov/22629405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinin B1 receptor antagonists with multi-enzymatic resistance properties

1 reference

https://pubmed.ncbi.nlm.nih.gov/22629405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0037485

0 references

2012PLoSO...737485C

0 references

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27302402&oldid=1867659024"